MARKET WIRE NEWS

Acurx Pharmaceuticals, Inc. (ACXP) Q2 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-08-12 10:13:48 ET

Acurx Pharmaceuticals, Inc. (ACXP)

Q2 2025 Earnings Conference Call

August 12 2025, 08:00 AM ET

Company Participants

David P. Luci - Co-Founder, President, CEO, Corporate Secretary & Director

Robert G. Shawah - Co-Founder & CFO

Conference Call Participants

James Francis Molloy - Alliance Global Partners, Research Division

Matthew Keller - H.C. Wainwright & Co, LLC, Research Division

Presentation

Operator

Greetings, and welcome to the Acurx Pharmaceuticals to discuss second quarter 2025 Financial results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Robert Shawah, Chief Financial Officer. Please go ahead....

Read the full article on Seeking Alpha

For further details see:

Acurx Pharmaceuticals, Inc. (ACXP) Q2 2025 Earnings Call Transcript
Acurx Pharmaceuticals Inc.

NASDAQ: ACXP

ACXP Trading

26.73% G/L:

$1.765 Last:

844,579 Volume:

$1.38 Open:

mwn-link-x Ad 300

ACXP Latest News

ACXP Stock Data

$5,246,237
2,029,733
5.06%
9
N/A
Biotechnology & Life Sciences
Healthcare
US
Staten Island

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App